Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Rituximab treatment led to complete hair regrowth and improved skin in a woman with pemphigus foliaceus.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Baricitinib helps treat severe hair loss in people over 65.

Brevilin-A is a safe and effective treatment for mild to moderate alopecia areata in children.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

Infliximab successfully treated a severe hair loss case in Sri Lanka.

Baricitinib showed mixed results in treating alopecia areata in children, with some improvement but also side effects.

Anti-TNF therapy can cause hair loss and skin issues.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Certain medications can cause serious side effects, so it's important to report them.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Oral baricitinib is effective and safe for treating alopecia areata.

Bexarotene gel shows promise as a new treatment for alopecia areata.

The decision board effectively helps lupus nephritis patients in Brazil choose treatments by clearly presenting options and side effects.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

A new mix of anthralin and calcipotriene might help treat severe hair loss.